BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) perform limited physical activity. Surprisingly, there is a lack of research in COPD about the validity of physical activity questionnaires. Our aim was to validate the Yale Physical Activity Survey in COPD patients in order to quantify and classify their levels of physical activity. METHODS: 172 COPD patients from 8 university hospitals in Spain wore an accelerometer (SenseWear(®)Pro(2)Armband) for 8 days and answered the questionnaire 15 days later. Statistical analyses used to compare both tools measures included: (i) Spearman's correlation coefficient, (ii) intraclass correlation coefficient (ICC) and Bland-Altman plots, (iii) distribution of accelerometer measurements according to tertiles of the questionnaire, and (iv) receiver operating characteristic (ROC) curves to detect sedentary patients. RESULTS: 94% of participants were men, 28% were active smokers and 7% were currently working. Mean (standard deviation) age was 70 (8) years, mean post-bronchodilator FEV(1) was 52 (15)% predicted, and median (p25-p75) steps taken was 5,702 (3,273-9,253) steps per day(-1). Spearman correlations were low to moderate (from 0.29 to 0.52, all P<.001). ICCs showed weak agreement (from 0.34 to 0.40, all P<.001). A wide variability in agreement was observed in the Bland-Altman plots. Significant differences in accelerometer measurements were found according to questionnaire tertiles (all P<.001). The area under the ROC for identifying sedentarism was 0.71 (95% CI: 0.63-0.79). CONCLUSIONS: The Yale Physical Activity Survey may be a valid tool to classify, but not to quantify, physical activity performed by COPD patients. The summary index of this questionnaire, based on seven short questions, shows the best validity properties. This suggests that it should be considered a screening tool to identify patients at risk for sedentarism.
BACKGROUND:Patients with chronic obstructive pulmonary disease (COPD) perform limited physical activity. Surprisingly, there is a lack of research in COPD about the validity of physical activity questionnaires. Our aim was to validate the Yale Physical Activity Survey in COPDpatients in order to quantify and classify their levels of physical activity. METHODS: 172 COPDpatients from 8 university hospitals in Spain wore an accelerometer (SenseWear(®)Pro(2)Armband) for 8 days and answered the questionnaire 15 days later. Statistical analyses used to compare both tools measures included: (i) Spearman's correlation coefficient, (ii) intraclass correlation coefficient (ICC) and Bland-Altman plots, (iii) distribution of accelerometer measurements according to tertiles of the questionnaire, and (iv) receiver operating characteristic (ROC) curves to detect sedentary patients. RESULTS: 94% of participants were men, 28% were active smokers and 7% were currently working. Mean (standard deviation) age was 70 (8) years, mean post-bronchodilator FEV(1) was 52 (15)% predicted, and median (p25-p75) steps taken was 5,702 (3,273-9,253) steps per day(-1). Spearman correlations were low to moderate (from 0.29 to 0.52, all P<.001). ICCs showed weak agreement (from 0.34 to 0.40, all P<.001). A wide variability in agreement was observed in the Bland-Altman plots. Significant differences in accelerometer measurements were found according to questionnaire tertiles (all P<.001). The area under the ROC for identifying sedentarism was 0.71 (95% CI: 0.63-0.79). CONCLUSIONS: The Yale Physical Activity Survey may be a valid tool to classify, but not to quantify, physical activity performed by COPDpatients. The summary index of this questionnaire, based on seven short questions, shows the best validity properties. This suggests that it should be considered a screening tool to identify patients at risk for sedentarism.
Authors: Eva Balcells; Elena Gimeno-Santos; Jordi de Batlle; Maria Antonia Ramon; Esther Rodríguez; Marta Benet; Eva Farrero; Antoni Ferrer; Stefano Guerra; Jaume Ferrer; Jaume Sauleda; Joan A Barberà; Àlvar Agustí; Robert Rodriguez-Roisin; Joaquim Gea; Josep M Antó; Judith Garcia-Aymerich Journal: BMC Pulm Med Date: 2015-01-17 Impact factor: 3.317
Authors: Elena Gimeno-Santos; Yogini Raste; Heleen Demeyer; Zafeiris Louvaris; Corina de Jong; Roberto A Rabinovich; Nicholas S Hopkinson; Michael I Polkey; Ioannis Vogiatzis; Maggie Tabberer; Fabienne Dobbels; Nathalie Ivanoff; Willem I de Boer; Thys van der Molen; Karoly Kulich; Ignasi Serra; Xavier Basagaña; Thierry Troosters; Milo A Puhan; Niklas Karlsson; Judith Garcia-Aymerich Journal: Eur Respir J Date: 2015-05-28 Impact factor: 16.671
Authors: Magdalena Król-Zielińska; Jacek Zieliński; Adam Kantanista; Robert Szeklicki; Wiesław Osiński; Monika Ciekot-Sołtysiak Journal: Int J Environ Res Public Health Date: 2019-07-06 Impact factor: 3.390
Authors: M V Castell; A Gutiérrez-Misis; M Sánchez-Martínez; M A Prieto; B Moreno; S Nuñez; R Triano; M P de Antonio; C Mateo; M D Cano; A Garrido; R Julian; E Polentinos; R Rodriguez-Barrientos; A Otero Puime Journal: BMC Geriatr Date: 2019-01-28 Impact factor: 3.921
Authors: Javier Sanchez-Lopez; Juan Silva-Pereyra; Thalía Fernández; Graciela C Alatorre-Cruz; Susana A Castro-Chavira; Mauricio González-López; Sergio M Sánchez-Moguel Journal: PLoS One Date: 2018-01-25 Impact factor: 3.240
Authors: Alexandre Caron; Alba Ayala; Javier Damián; Carmen Rodriguez-Blazquez; Javier Almazán; Juan Manuel Castellote; Madgalena Comin; Maria João Forjaz; Jesús de Pedro Journal: BMC Geriatr Date: 2017-07-18 Impact factor: 3.921
Authors: Noriane A Sievi; Thomas Brack; Martin H Brutsche; Martin Frey; Sarosh Irani; Jörg D Leuppi; Robert Thurnheer; Malcolm Kohler; Christian F Clarenbach Journal: Int J Chron Obstruct Pulmon Dis Date: 2017-04-10